medicines and side effects

Similar documents
MEDICAL DEVICES. our advice on. automated external. defibrillators

Automated external defibrillators

Notice Information: - Advisory 01 November 2010

PACKAGE LEAFLET: INFORMATION FOR THE USER. DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate)

Havrix Monodose Vaccine Hepatitis A Vaccine (Inactivated, adsorbed) ELISA Units/1 ml Suspension for Injection in a pre-filled syringe

Package leaflet: Information for the user. Irprestan 150 mg film-coated tablets. Irprestan 300 mg film-coated tablets irbesartan

PATIENT INFORMATION BOOKLET

Package leaflet: Information for the patient. Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride)

How Entecavir GH Works

Atrosan Devil s Claw film-coated tablets

Package leaflet: Information for the user Zinforo 600 mg powder for concentrate for solution for infusion Ceftaroline fosamil

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

Tacrolimus. Information for Parents/Carers

PACKAGE LEAFLET: INFORMATION FOR THE USER. DUKORAL suspension and effervescent granules for oral suspension Cholera vaccine (inactivated, oral)

The name of this medicine is Vepesid. Each capsule contains etoposide (either 50 mg or 100 mg) as the active ingredient.

Package leaflet: Information for the user. HBVAXPRO 5 micrograms, suspension for injection in pre-filled syringe Hepatitis B vaccine (rdna)

PHOLCODINE. Please follow the instructions on the packaging of the medicine you purchased and in this leaflet before you start using pholcodine.

HAVRIX 1440 and HAVRIX Junior

Package leaflet: Information for the patient. SIRTURO 100 mg tablets Bedaquiline

Anticoagulation in Atrial Fibrillation Patient information

NHS Greater Glasgow And Clyde Pain Management Service. Information for Adult Patients who are Prescribed. Pregabalin. For the Treatment of Pain

ACT-HIB powder and solvent for solution for injection Haemophilus influenzae type b Conjugate Vaccine

Package leaflet: Information for the patient. Olumiant 2 mg film-coated tablets Olumiant 4 mg film-coated tablets Baricitinib

Important Information for Patients in the UK and Republic of Ireland HOLOCLAR

Abatacept. What is abatacept?

Package leaflet: Information for the patient. Heparin Sodium BP 1000 IU/L in 0.9% w/v Sodium Chloride IV Infusion. Active substance: Heparin Sodium

IMPORTANT INFORMATION

Hydrocortisyl Skin Cream 1% Hydrocortisone

Package leaflet: Information for the user. HBVAXPRO 40 micrograms, suspension for injection Hepatitis B vaccine (rdna)

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

CAPRELSA. (vandetanib)

Medicines in Scotland: What s the right treatment for me? Information for patients and the public

Getting the best from the medicines you buy

Package leaflet: Information for the user. Poliomyelitis Vaccine (Inactivated) suspension for injection in pre-filled syringe

Soliris (eculizumab): Paroxysmal nocturnal haemoglobinuria (PNH) Patient/Parent information brochure

Package leaflet: Information for the user

If you have any concerns about using this medicine, ask your doctor or pharmacist.

MERIEUX INACTIVATED RABIES VACCINE (MIRV) Rabies Vaccine

Valaciclovir generichealth Treatment of herpes simplex

Oral Systemic Therapy

OSTEOCIS. PACKAGE LEAFLET: INFORMATION FOR THE PATIENT OSTEOCIS 3 mg kit for radiopharmaceutical preparation sodium oxidronate

NHS Greater Glasgow And Clyde Pain Management Service. Information for Adult Patients who are Prescribed. Carbamazepine. For the Treatment of Pain

Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine

Medication Use safety Training FOR SENIORS

Oral N-Acetyl CystieneTablets. Patient Information

Oral Systemic Therapy

THYROGEN Thyrotropin alfa-rch, powder for injection

Package leaflet: Information for the user. Lidocaine Hydrochloride 1% w/v Solution for Injection Lidocaine Hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the patient. Selincro 18 mg film-coated tablets nalmefene

All medicines have risks and benefits. Your doctor has weighed the risks of you taking Triprim against the benefits he or she expects it will have.

Patient Leaflet : Information for the user Locoid Cream 0.1% w/w Hydrocortisone butyrate

Package leaflet: Information for the user. Elaprase 2 mg/ml concentrate for solution for infusion idursulfase

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT

Medicines to treat pain in adults. Information for patients and carers

LGP CLASSIC Oil Products

Guide for Patients & Caregivers

PATIENT INFORMATION LEAFLET. DOTAREM mg/ml, solution for injection (Gadoteric acid)

AUGMENTIN is also used to prevent infection from major surgery.

Package leaflet: Information for the patient

PACKAGE LEAFLET: INFORMATION FOR THE USER. Echinaforce Cold & Flu oral drops Echinacea purpurea herb & root tinctures

Pravat 40 mg tablets. Pravastatin sodium

PHENYLEPHRINE. Please read this leaflet and the label of the medicine you purchased, carefully before you start using Phenylephrine.

PATIENT INFORMATION LEAFLET

1. What Betahistine dihydrochloride tablets is and what it is used for

Imodium 1 mg/5 ml oral solution

1. What Faslodex is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE USER. Pneumococcal Polysaccharide Vaccine

Package leaflet: Information for the user. Tuberculin PPD RT23 "SSI" 2 T.U./0.1 ml, solution for injection Tuberculin PPD RT 23

DUKORAL. Oral inactivated cholera and ETEC vaccine. Consumer Medicine Information. It does not take the place of talking to your doctor or pharmacist.

PACKAGE LEAFLET: INFORMATION FOR THE USER RENNIE DUAL ACTION TABLETS. Calcium carbonate, Magnesium carbonate, Alginic acid Chewable tablets

NHS Greater Glasgow And Clyde Pain Management Service. Information for Adult Patients who are Prescribed. Duloxetine. For the Treatment of Pain

Package leaflet: Information for the patient. Selenium 10 micrograms/ml concentrate for solution for infusion. Sodium selenite

Why have I been selected for treatment with adalimumab?

PACKAGE LEAFLET: INFORMATION FOR THE USER. PEGLAX 10g Powder for oral solution in sachet. Macrogol 4000

PATIENT INFORMATION LEAFLET

HEPATYRIX (Combined inactivated hepatitis A and Vi polysaccharide typhoid vaccine) CONSUMER MEDICINE INFORMATION LEAFLET

PACKAGE LEAFLET: INFORMATION FOR THE USER. ZADITEN 1 mg/5 ml Oral Solution. Ketotifen (as Ketotifen hydrogen fumarate)

AUSTRAPEN ampicillin (as sodium)

Colofac mebeverine hydrochloride

TYPHIM Vi. Purified polysaccharide capsule of Salmonella typhi (Ty 2 strain) Consumer Medicine Information

Sanomigran 500 microgram Tablets and Sanomigran 1.5 mg Tablets

TYPHIM Vi, Solution for injection

Package leaflet: Information for the patient. Tranexamic Acid 100 mg/ml, Solution for Injection tranexamic acid

PACKAGE LEAFLET: INFORMATION FOR THE USER. Venaforce Varicose Veins gastro-resistant tablets Horse Chestnut seed dry extract

MERIEUX INACTIVATED RABIES VACCINE (MIRV)

Mycophenolate mofetil (MMF) for Myasthenia

PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM FERRERI / IELSG PROTOCOL. Patient s first names. Date of birth

PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride

(sunitinib malate) for Kidney Cancer

Consumer Medicine Information March 2009

VALPROATE. (Epilim, Depakote ) Patient Information Booklet

What to expect after immunisations. This leaflet tells you what common side effects might occur after immunisation and what to do about them.

Package leaflet: Information for the user

Package leaflet: Information for the user. Levonorgestrel 1.5 mg Tablet. levonorgestrel

Starting with Tivicay

Tiorfan Hidrasec Tiorfix Tiorfast 100 mg PACKAGE LEAFLET

Transcription:

human medicines our advice on medicines and side effects

medicines title and side effects Medicines can help people live longer and healthier lives. They can help cure or treat an illness or disease and can also prevent some conditions from developing in the first place. During the course of our lives, it is likely that we will all need to take medicines. These might include vaccines to prevent illness or prescription medicines such as antibiotics to treat serious infections. Over-the-counter medicines are also available and include products to treat minor symptoms like headaches as well as dietary supplements. Most of us will not experience any problems when using medicines. However, all medicines have some risks associated with their use and so a small number of people may develop side effects (also known as adverse reactions). This leaflet provides useful information about what you should do if you believe that you have had a side effect to a medicine. Side effect = Adverse reaction

Most of us will not experience any problems when using medicines. However, all medicines have some risks associated with their use What is a side effect? A side effect or adverse reaction is an unwanted or unintentional reaction that a person may experience after taking a medicine. In many cases, side effects to medicines are mild and do not mean that you have to stop taking the medicine. However, for some people, the side effects can sometimes be more serious and may require a change in treatment or, in rare cases, some additional medical treatment. While many people take medicines without any problems, all medicines carry some risks. These risks should be looked at in the context of the overall benefit of a medicine to a person s health and the condition being treated. Even where a reaction to a particular medicine is severe, it may still be beneficial to prevent the complications of the underlying illness by continuing the treatment and managing the unwanted effects at the same time.

medicines and side effects Where can I get information on side effects? The package leaflet that accompanies a medicine is intended to provide people with information about that medicine. A very important part of this leaflet is the section dealing with potential side effects. Some of this information may also be printed on the product packaging. It is really important that you take the time to read this information. In addition, when your doctor prescribes a medicine for you, take time to talk about the possible side effects of the medicine they are recommending for you. What are the chances of having a side effect? The package leaflet provides information about the potential side effects of a medicine and the chances of developing those side effects. For example, a very rare side effect affects fewer than 1 in 10,000 people. A very common side effect is one that affects more than 1 in 10 people taking the medicine.

When your doctor prescribes a medicine, take time to talk with him or her about the possible side effects of the medicine they are recommending

medicines and side effects How do I know if I have had a side effect to a medicine? Side effects vary and depend on the medicine and the person. Examples of common side effects include headaches, fever, dizziness, skin rashes, nausea, vomiting, diarrhoea and drowsiness. Some side effects may happen immediately while others may develop over a period of time. However, many side effects to medicines are mild and will go away within a few days as your body adjusts to the medicine. What should I do if I think I have had a side effect? If you are concerned that you have had a side effect to a medicine, contact your doctor or pharmacist who will advise on any treatment you may need. They may also report the suspected side effect to the Irish Medicines Board (IMB). Should you wish, you can also report side effects directly to the IMB. While a report of a side effect does not necessarily mean that it is has been caused by the medicine you took, the IMB encourages people to report all suspected side effects.

In many cases, side effects to medicines are mild and will go away within a few days as your body adjusts to the medicine

If you have any concerns about a potential side effect that you may have experienced after taking a medicine, contact your doctor or pharmacist

Why do I need to report a side effect? It is very important that suspected side effects from the use of a medicine are reported as these reports allow the IMB to monitor the safety of each product as it is used. It is also an important way of identifying any new potential safety issues with medicines. When the IMB receives a report of a suspected side effect, it evaluates the case and considers whether this may be a new safety concern or whether similar cases have been previously reported. The IMB also has access to global safety information which helps in identifying emerging safety issues. When new safety issues are identified, the IMB may, if appropriate, instruct the company concerned to include this new information on the package leaflet. It may also inform healthcare professionals of the new information. Where a serious safety issue emerges with a medicine, the IMB has the power to vary the way that product is used or to suspend the sale of the product if it poses a risk to public health.

medicines and side effects What can I do to minimise the risk of side effects? Always follow the advice of your doctor and pharmacist on the recommended storage, dose and length of time you should take a medicine. Make sure you tell your doctor and pharmacist about any other medicines you are taking. Some medicines can react with each other and this could pose a health risk. How can I report a side effect? You can report a suspected side effect or adverse reaction in a number of ways: 1. To your doctor, pharmacist, dentist or nurse who can then notify the IMB. They will also consider if you need to adjust your treatment or if you will need an alternative treatment. 2. On the IMB website www.imb.ie 3. By calling the IMB on (01) 676 4971

The Irish Medicines Board The Irish Medicines Board s role is to protect and enhance public and animal health through the regulation of medicines, medical devices and healthcare products. What does the IMB do? As the regulatory authority, the IMB monitors the safety of medicines available in Ireland. It aims to ensure that all medicines purchased here are safe, effective and of high quality. The IMB identifies and addresses safety issues so that medicines do not compromise the health of patients. More Information This is one in a series of information leaflets that are available from the IMB and from the IMB website, www.imb.ie.

medicines and side effects human MEDICines Irish Medicines Board Bord Leigheasra na héireann Kevin O Malley House Earlsfort Centre Earlsfort Terrace Dublin 2 Phone: (01) 676 4971 Fax: (01) 634 4033 E-mail: imb@imb.ie www.imb.ie